Genomic Vision

Page d'Accueil
France
Paris
Genomic Vision

Biotechnology company specialized in molecular diagnostics solutions and in the development of DNA detection tools used for research and in vitro diagnosis

An innovative company in Clinical Diagnosis

Genomic Vision’s technology opens a new perspective for the structural and functional analysis of the genome

The technology combines Molecular Combing, a proprietary technique to untangle single DNA molecules, with a unique detection strategy, the Genomic Morse Code. Genomic Vision’s solution fulfills an unmet medical and research need by enabling the

analysis of large scale genome changes that are implicated in pathology and remain frequently hidden or inaccurately detected by other technologies. Contributing to scientific research

Thanks to its expertise in molecular combing, and its close relations with academic sector, Genomic Vision offers a new approach to spatiotemporal analysis of DNA replication.

23/06/2017

Researchers have capture the replication of a single DNA molecule on video for the first time.

DNA: It's just like us.

20/06/2017

Genomic Vision supports the world FSHD Day and the patients, families and physicians it serves every day
https://www.fshsociety.org/

23/05/2017

Le Revenu – Interview of Stephane Altaba, VP Corporate Development of Genomic Vision following the technological collaboration signed with AstraZeneca in oncology to study WEE1 inhibition using Molecular Combing

La biotech, issue de l’institut Pasteur et spécialisée dans le diagnostic moléculaire, a annoncé, mardi 23 mai, la signature d’un partenariat avec le géant britannique de la pharmacie Astra-Zeneca.

09/05/2017

Save the date - May 10 - - R&D day - Presentation diagnostic programs

28/02/2017

Today is !
Genomic Vision’s supports Rare Disease Day and the FSHD patients, families, and physicians it serves every day.
http://www.rarediseaseday.org/

The main objective of Rare Disease Day 2017 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.

24/01/2017

TCGA study identifies genomic features of cervical cancer
https://lc.cx/JcE5

Using The Cancer Genome Atlas scientists have identified novel genomic characteristics of cervical cancer that could be used to target therapies

10/01/2017

Press Release: Financial information at December 31st, 2016.
Genomic Vision doubles its installed base of FiberVision® platforms and quadruples its sales of products & services.
https://miniurl.be/r-1apg

Financial information at September 30, 2016 and implementation of a flexible financing via the reserved issuance of convertible notes with warrants

06/01/2017

Genomic Vision will participate at the Keystone Symposia on Molecular and Cellular Biology Precision Engineering taking place in Colorado.
We look forward to discussing about our solutions for genome engineering https://lc.cx/JimP

06/01/2017

The gene-editing tool’s potential to upend science is dizzying.

30/11/2016

Come visit us at at in . http://www.pasteur-network-meeting2016.org/

25/03/2016

Maximization of Molecular Combing’s potential on the Life Sciences Research Tools market http://goo.gl/ilfCr1

> Maximization of molecular combing’s potential: targeting of the major and accessible Life Sciences Research Tools (LSRT) market

Adresse

80 Rue Des Meuniers
Paris
92220

Site Web

http://www.genomicvision.com/contact-us/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Genomic Vision publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.